Not yet recruitingPhase 2NCT07424092

Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors

Studying Ependymoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Principal Investigator
Jaime Gállego Pérez de Larraya, M.D., Ph.D.
Cancer Center Clínica Universidad de Navarra
Intervention
DNX-2401(biological)
Enrollment
39 enrolled
Eligibility
1-25 years · All sexes
Timeline
2026 – 2029

Study locations (2)

Collaborators

Princess Maxima Center for Pediatric Oncology · Asociación Española contra el Cáncer

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07424092 on ClinicalTrials.gov

Other trials for Ependymoma

Additional recruiting or active studies for the same condition.

See all trials for Ependymoma →

← Back to all trials